top of page

Shiri Shulman MD:

 

Non- infectious inflammatory response Following Intravitreal Bevascizumab Injections: A cluster of Cases in Two Centers

Nimesh Patel MD, Anat Galor MD:

 

Oral Tacrolimus for the Treatment of Refractory Atopic Keratoconjunctivitis and Dermatitis

Adnan Mallick, M.D.:

 

Neuro-imaging in the Emergency Room (ER) setting in patients with Vitreo-retinal symptoms.

Colin R Green:

​

Connexin43 (Cx43) and the inflammasome pathway; Effective Therapeutic Targets in Serious Eye Disease

Sophia Seen, Rupesh Agrawal:

 

Title: Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS) – Report 3: Posterior and Panuveitis

Gary D. Novack, Ph.D.:

 

New therapies for ocular Inflammation – patient and investor perspectives

Colin R Green – Brian Levy:

 

Connexin43 (Cx43) the Inflammasome Pathway and treatment of Non Responsive Persistent Corneal Epithelial Defects (PED)

Elliot S. Crane*, May Shum, Jason Kim, Eliott Kim, Alexander B. Crane, David S. Chu:

 

Epidemiology and Outcomes of Intermediate Uveitis

L. Edward Clemens, Jesse Jaynes, Alison McDermott, Kathryn Woodburn:

 

Designed Host Defense Peptides for the Treatment of Bacterial Keratitis

Christine Clavell, MD and Marco Zarbin, MD, PhD:

 

The role of early vitrectomy in ocular syphilis

Natalia F. Callaway, MD:

 

Outcomes of Pars Plana Vitrectomy for Patients with Inflammatory Macular Holes

Will Ayliffe Ph.D, FRCS.:

 

Blepharitis

Will Ayliffe Ph.D, FRCS.: Retinal

 

Vasculitis

bottom of page